Neurology Articles
A scientific hub to keep you informed about our latest research and company updates.
New insights into TDP-43 mouse model pathophysiology
InnoSer and CureSHANK partner to launch industry-quality preclinical testing service for Phelan-McDermid syndrome (PMS) treatments
Accelerating Angelman Syndrome Research: InnoSer now offers Angelman Syndrome Mouse Model
InnoSer Partners with Kabuki Syndrome Foundation to Advance Therapeutic Development for Kabuki Syndrome
InnoSer Presents New Data on Tau[P301S] and α-Synuclein Combination Models for Neurodegenerative Research at ADPD 2025
InnoSer Strengthens Neurology Platform with Acquisition of remynd’s CRO Business
Gene Therapy Delivery Strategies: Helping You Address Challenges for CNS Diseases
How to Advance your Preclinical Research Using Mouse Data to Establish PK/PD Relationships
MDX Mouse Model Validation Data
InnoSer Announces Joint Initiative with Hasselt University/BIOMED to Support Preclinical Multiple Sclerosis Research
Introduction to InnoSer’s Preclinical Epilepsy Research CRO Platform
info@innoserlaboratories.com





![InnoSer Presents New Data on Tau[P301S] and α-Synuclein Combination Models for Neurodegenerative Research at ADPD 2025](https://www.innoserlaboratories.com/wp-content/uploads/2025/03/ADPD-2025-InnoSer-Neurodegenerative-Disease-Models-400x250.png)





